Saxenda and Victoza's active ingredient is liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed to patients suffering from type 2 diabetes or obesity. The following health risks have been associated with both medications:
- Gastroparesis - A partial or complete paralysis of the stomach. This condition makes it harder for people to digest food, which can eventually lead to more problems such as nausea, vomiting, abdominal pain, and more. It's an untreatable condition.
- Vision loss - Saxenda and Victoza specifically cause a form of vision loss called non-arteritic anterior ischemic optic neuropathy (NAION). This happens when there's insufficient blood flow to the optic nerve, causing damage. This type of vision loss is sudden, painless, and untreatable.
- Bowel obstruction - Since GLP-1 RAs slow down gastric emptying, there's a chance that it can cause food blockages and bezoar formation in your intestines. In severe cases, this can result in the death of certain parts of the intestine.
Atraxia Law can check if you're eligible for a Saxenda claim
These linkable health conditions can gravely affect your quality of life. If you've been diagnosed with any of these due to Saxenda or Victoza treatment, you should file a claim against Novo Nordisk. We can assess your eligibility after you give us medical records that can prove your injury.
